Provided by Tiger Trade Technology Pte. Ltd.

Crescent Biopharma Inc

16.89
+0.12000.72%
Post-market: 16.84-0.0500-0.30%19:30 EDT
Volume:3.12M
Turnover:52.88M
Market Cap:627.36M
PE:-2.28
High:17.87
Open:16.67
Low:16.15
Close:16.77
52wk High:27.41
52wk Low:8.72
Shares:37.14M
Float Shares:15.95M
Volume Ratio:7.55
T/O Rate:19.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.4105
EPS(LYR):-12.8150
ROE:-160.75%
ROA:-69.15%
PB:8.65
PE(LYR):-1.32

Loading ...

Sep 18, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 16, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 14, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jul 30, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 30, 2026

Major Issues Report

Form 8-K - Current report
Jul 15, 2026

Major Issues Report

Form 8-K - Current report
Jul 14, 2026

Major Issues Report

Form 8-K - Current report
Jun 22, 2026

[Rev.]Quaterly Report

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
Jun 03, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Apr 29, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 26, 2026

Major Issues Report

Form 8-K - Current report
Feb 26, 2026

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 14, 2026

Correspondence

Form CORRESP - Correspondence